Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV

Virology

Volumn 358, Issue 2, 2007, Pages 373-383

  Rivera Amill, Vanessa ^a   Noel Jr , Richard J ^a   Orsini, Suheydi ^a   Tirado, Griselle ^a   García, José M ^a   Buch, Shilpa ^b   Kumar, Anil ^a,c  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Envelope evolution; Macaque; Morphine; SHIV; SIV; Variable region

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; ENVELOPE GENE; EVOLUTION; GENE SEQUENCE; GENETIC VARIABILITY; INOCULATION; MACACA; MORPHINE ADDICTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENETIC VARIATION; HIV-1; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MORPHINE; MORPHINE DEPENDENCE; PHYLOGENY; REASSORTANT VIRUSES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33846351180     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.039     Document Type: Article

References (45)

1. Alcabes P., and Friedland G. Injection drug use and human immunodeficiency virus infection. Clin. Infect. Dis. 20 (1995) 1467-1479
2. Bonyhadi M.L., and Kaneshima H. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Mol. Med. Today 3 (1997) 246-253
3. CDC. HIV and AIDS-United States, 1981-2000. MMWR Morb. Mortal. Wkly. Rep. 50 (2001) 430-434
4. CDC. HIV diagnoses among injection-drug users in states with HIV surveillance-25 states, 1994-2000. MMWR Morb. Mortal. Wkly. Rep. 52 (2003) 634-636
5. Cho M.W., Lee M.K., Carney M.C., Berson J.F., Doms R.W., and Martin M.A. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J. Virol. 72 (1998) 2509-2515
6. Chu T.X., and Levy J.A. Injection drug use and HIV/AIDS transmission in China. Cell Res. 15 (2005) 865-869
7. Cohn J.A. HIV-1 infection in injection drug users. Infect. Dis. Clin. North Am. 16 (2002) 745-770
8. Esparza J. Animal models for the evaluation of drugs and vaccines for HIV infection and AIDS: report of a WHO Working Group. Dev. Biol. Stand. 72 (1990) 367-372
9. Flaherty M.T., Hauer D.A., Mankowski J.L., Zink M.C., and Clements J.E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71 (1997) 5790-5798
10. Fultz P.N. Nonhuman primate models for AIDS. Clin. Infect. Dis. 17 Suppl. 1 (1993) S230-S235
11. Gardner M.B. Animal models for development of an AIDS vaccine. Int. Rev. Immunol. 7 (1990) 31-49
12. Guo C.J., Li Y., Tian S., Wang X., Douglas S.D., and Ho W.Z. Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J. Investig. Med. 50 (2002) 435-442
13. Haigwood N.L. Predictive value of primate models for AIDS. AIDS Rev. 6 (2004) 187-198
14. Hall TA. BioEdit: a user friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser 41, 95-98. Ref Type: Generic.
15. Harrowe G., and Cheng-Mayer C. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210 (1995) 490-494
16. Ho W.Z., Guo C.J., Yuan C.S., Douglas S.D., and Moss J. Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. J. Pharmacol. Exp. Ther. 307 (2003) 1158-1162
17. Hoffman T.L., Stephens E.B., Narayan O., and Doms R.W. HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11360-11365
18. Hu S.L. Non-human primate models for AIDS vaccine research. Curr. Drug Targets Infect. Disord. 5 (2005) 193-201
19. Hu Q.X., Barry A.P., Wang Z.X., Connolly S.M., Peiper S.C., and Greenberg M.L. Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J. Virol. 74 (2000) 11858-11872
20. Kerr C. Injection drug use fuels HIV/AIDS epidemic across Eurasia. Lancet Infect. Dis. 5 (2005) 539
21. Kinman L.M., Worlein J.M., Leigh J., Bielefeldt-Ohmann H., Anderson D.M., Hu S.L., Morton W.R., Anderson B.D., and Ho R.J. HIV in central nervous system and behavioral development: an HIV-2287 macaque model of AIDS. AIDS 18 (2004) 1363-1370
22. Kumar R., Torres C., Yamamura Y., Rodriguez I., Martinez M., Staprans S., Donahoe R.M., Kraiselburd E., Stephens E.B., and Kumar A. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J. Virol. 78 (2004) 11425-11428
23. Kumar S., Tamura K., and Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5 (2004) 150-163
24. Kumar, R., Orsoni, S., Norman, L., Verma, A.S., Tirado, G., Giavedoni, L.D., Staprans, S., Miller, G.M., Buch, S.J., and Kumar, A. 2006. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology. on line publication, PMID 16876224.
25. Levy J.A. The value of primate models for studying human immunodeficiency virus pathogenesis. J. Med. Primatol. 25 (1996) 163-174
26. Li Y., Merrill J.D., Mooney K., Song L., Wang X., Guo C.J., Savani R.C., Metzger D.S., Douglas S.D., and Ho W.Z. Morphine enhances HIV infection of neonatal macrophages. Pediatr. Res. 54 (2003) 282-288
27. Negroni M., and Buc H. Mechanisms of retroviral recombination. Annu. Rev. Genet. 35 (2001) 275-302
28. Noel Jr. R.J., and Kumar A. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques. Virology 346 (2006) 127-138
29. Noel Jr. R.J., Marrero-Otero Z., Kumar R., Chompre-Gonzalez G.S., Verma A.S., and Kumar A. Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. Virology 349 (2006) 440-452
30. Nowak M.A. Variability of HIV infections. J. Theor. Biol. 155 (1992) 1-20
31. Persidsky Y., Nottet H.S., Sasseville V.G., Epstein L.G., and Gendelman H.E. The development of animal model systems for HIV-1 encephalitis and its associated dementia. J. Neurovirol. 1 (1995) 229-243
32. Persidsky Y., Potula R., and Haorah J. Rodent model systems for studies of HIV-1 associated dementia. Neurotox. Res. 8 (2005) 91-106
33. Qian H.Z., Schumacher J.E., Chen H.T., and Ruan Y.H. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm. Reduct. J. 3 (2006) 4
34. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., and Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70 (1996) 6922-6928
35. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., and Letvin N.L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70 (1996) 3198-3206
36. Ren X., Sodroski J., and Yang X. An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins. J. Virol. 79 (2005) 5616-5624
37. Schweitzer C., Keller F., Schmitt M.P., Jaeck D., Adloff M., Schmitt C., Royer C., Kirn A., and Aubertin A.M. Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res. Virol. 142 (1991) 189-195
38. Singh D.K., McCormick C., Pacyniak E., Griffin D., Pinson D.M., Sun F., Berman N.E., and Stephens E.B. Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation. Virology 296 (2002) 39-51
39. Smyth R.J., Yi Y., Singh A., and Collman R.G. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J. Virol. 72 (1998) 4478-4484
40. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
41. Tirado G., and Kumar A. Evolution of SIV envelope in morphine-dependent rhesus macaques with rapid disease progression. AIDS Res. Hum. Retroviruses 22 (2006) 114-119
42. Tyndall M.W., Craib K.J., Currie S., Li K., O'Shaughnessy M.V., and Schechter M.T. Impact of HIV infection on mortality in a cohort of injection drug users. J. Acquired Immune Defic. Syndr. 28 (2001) 351-357
43. van Maanen M., and Sutton R.E. Rodent models for HIV-1 infection and disease. Curr. HIV Res. 1 (2003) 121-130
44. van Marle G., and Power C. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?. J. Neurovirol. 11 (2005) 107-128
45. Vodros D., and Fenyo E.M. Primate models for human immunodeficiency virus infection. Evolution of receptor use during pathogenesis. Acta Microbiol. Immunol. Hung. 51 (2004) 1-29